Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Foot | 15 | 2013 | 380 | 1.980 |
Why?
|
| Wound Healing | 13 | 2019 | 2805 | 1.320 |
Why?
|
| Podiatry | 1 | 2019 | 28 | 0.670 |
Why?
|
| Chorion | 1 | 2019 | 114 | 0.660 |
Why?
|
| Diabetic Neuropathies | 9 | 2013 | 405 | 0.640 |
Why?
|
| Amnion | 1 | 2019 | 197 | 0.600 |
Why?
|
| Foot Injuries | 1 | 2019 | 149 | 0.580 |
Why?
|
| Ankle Injuries | 2 | 2019 | 339 | 0.540 |
Why?
|
| Foot | 4 | 2009 | 575 | 0.350 |
Why?
|
| Wound Infection | 2 | 2010 | 246 | 0.350 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2015 | 1651 | 0.320 |
Why?
|
| Microcirculation | 6 | 2013 | 1273 | 0.290 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2009 | 488 | 0.280 |
Why?
|
| Stockings, Compression | 1 | 2006 | 36 | 0.280 |
Why?
|
| Skin Care | 1 | 2006 | 57 | 0.270 |
Why?
|
| Osteomyelitis | 1 | 2010 | 407 | 0.260 |
Why?
|
| Skin, Artificial | 1 | 2006 | 89 | 0.250 |
Why?
|
| Diabetes Complications | 2 | 2009 | 1315 | 0.250 |
Why?
|
| Bandages | 1 | 2006 | 269 | 0.240 |
Why?
|
| Tissue Engineering | 1 | 2015 | 1868 | 0.240 |
Why?
|
| Skin | 5 | 2013 | 4484 | 0.230 |
Why?
|
| Debridement | 1 | 2006 | 494 | 0.230 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2226 | 0.220 |
Why?
|
| Foot Ulcer | 3 | 2007 | 63 | 0.200 |
Why?
|
| Muscle, Skeletal | 4 | 2013 | 4948 | 0.190 |
Why?
|
| Phosphocreatine | 2 | 2013 | 261 | 0.180 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 1489 | 0.180 |
Why?
|
| Biocompatible Materials | 1 | 2006 | 1685 | 0.150 |
Why?
|
| Surgical Wound Infection | 2 | 2007 | 1527 | 0.150 |
Why?
|
| Collagen | 1 | 2006 | 2638 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3688 | 0.130 |
Why?
|
| Inflammation Mediators | 3 | 2013 | 1886 | 0.120 |
Why?
|
| Regional Blood Flow | 3 | 2009 | 1496 | 0.110 |
Why?
|
| Fumarates | 1 | 2013 | 131 | 0.100 |
Why?
|
| Cytokines | 4 | 2013 | 7396 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 96 | 0.100 |
Why?
|
| Diabetes Mellitus | 2 | 2009 | 5840 | 0.090 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 678 | 0.090 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 496 | 0.090 |
Why?
|
| Amides | 1 | 2013 | 449 | 0.090 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2012 | 592 | 0.090 |
Why?
|
| Diabetic Angiopathies | 2 | 2013 | 803 | 0.090 |
Why?
|
| Microbiological Techniques | 1 | 2010 | 97 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 632 | 0.080 |
Why?
|
| Calcitonin | 1 | 2010 | 329 | 0.080 |
Why?
|
| Chemokines | 1 | 2012 | 960 | 0.070 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2010 | 323 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 1493 | 0.070 |
Why?
|
| Arthropathy, Neurogenic | 1 | 2006 | 29 | 0.070 |
Why?
|
| Endothelium, Vascular | 3 | 2009 | 4431 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2010 | 774 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1596 | 0.060 |
Why?
|
| Calcaneus | 1 | 2007 | 142 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2010 | 1132 | 0.060 |
Why?
|
| Phosphates | 1 | 2009 | 770 | 0.060 |
Why?
|
| Orthotic Devices | 1 | 2006 | 129 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2007 | 15631 | 0.060 |
Why?
|
| Reference Values | 2 | 2009 | 4920 | 0.060 |
Why?
|
| Microvessels | 1 | 2009 | 577 | 0.060 |
Why?
|
| Humans | 23 | 2019 | 761504 | 0.060 |
Why?
|
| Growth Substances | 1 | 2006 | 768 | 0.060 |
Why?
|
| Physical Examination | 1 | 2010 | 1255 | 0.060 |
Why?
|
| Morbidity | 1 | 2009 | 1750 | 0.060 |
Why?
|
| Reflex | 1 | 2005 | 376 | 0.050 |
Why?
|
| Disease Progression | 2 | 2012 | 13506 | 0.050 |
Why?
|
| Biopsy | 2 | 2013 | 6766 | 0.050 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 1273 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3548 | 0.050 |
Why?
|
| Stem Cells | 1 | 2013 | 3522 | 0.050 |
Why?
|
| Atrophy | 1 | 2005 | 1633 | 0.040 |
Why?
|
| Risk | 1 | 2012 | 9610 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3624 | 0.040 |
Why?
|
| Boston | 1 | 2012 | 9326 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2013 | 12148 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 3826 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2009 | 2882 | 0.040 |
Why?
|
| Forearm | 2 | 2013 | 427 | 0.040 |
Why?
|
| Risk Factors | 4 | 2010 | 74206 | 0.040 |
Why?
|
| Inflammation | 3 | 2013 | 10773 | 0.030 |
Why?
|
| Axons | 1 | 2005 | 1674 | 0.030 |
Why?
|
| Exercise | 1 | 2013 | 5890 | 0.030 |
Why?
|
| Vasodilation | 2 | 2013 | 962 | 0.030 |
Why?
|
| Middle Aged | 10 | 2013 | 220895 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14666 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 20098 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2006 | 2046 | 0.030 |
Why?
|
| Mass Screening | 1 | 2010 | 5428 | 0.030 |
Why?
|
| Oxygen | 1 | 2005 | 4227 | 0.030 |
Why?
|
| Incidence | 1 | 2012 | 21353 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 5073 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2008 | 9318 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2010 | 36426 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 5492 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2013 | 22176 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7390 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2013 | 176 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 3415 | 0.020 |
Why?
|
| Male | 10 | 2013 | 360804 | 0.020 |
Why?
|
| Female | 10 | 2013 | 392644 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39106 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 629 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 41487 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 14031 | 0.020 |
Why?
|
| Aged | 5 | 2013 | 169289 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 1648 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2013 | 1201 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 54425 | 0.020 |
Why?
|
| Rabbits | 1 | 2013 | 4772 | 0.020 |
Why?
|
| Adult | 5 | 2013 | 221177 | 0.020 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2006 | 34 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 198 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2006 | 239 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 267 | 0.020 |
Why?
|
| Tritium | 1 | 2005 | 708 | 0.020 |
Why?
|
| Animals | 4 | 2013 | 168459 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 13367 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 64680 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3769 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4352 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2011 | 2690 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 1866 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2007 | 1615 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2009 | 3550 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 1408 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2007 | 2885 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 58976 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 22169 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 39967 | 0.010 |
Why?
|
| Hospitalization | 1 | 2011 | 10723 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 12953 | 0.000 |
Why?
|
| Mice | 1 | 2013 | 81525 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 59243 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 80636 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_